Skip to Content
Sharon M Weber, MD, FACS

Contact Dr. Weber

E-mail:
webers@surgery.wisc.edu

Phone:
(608) 262-2025

Mail:
600 HIGHLAND AVE
BX7375 CLINICAL SCIENCE CNTR
MADISON, WI 53792-3284

Fax:
(608) 252-0913

Sharon M Weber, MD, FACS

Professor and Chief, Division of Surgical Oncology
Vice Chair of Academic Affairs, Divisions of General Surgery
Medical Director of Surgical Oncology, UW Carbone Cancer Center

Education

  • M.D, University of Wisconsin Medical School, Madison, WI, 1993
  • Residency in General Surgery, University of Wisconsin Hospital and Clinics, Madison, WI, 1993-1999
  • Research Fellowship in Tumor Immunotherapy, University of Wisconsin Medical School, Madison, WI, 1996-1997
  • Surgical Oncology Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY, 1999-2001
  • Hepatobiliary Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY, 2000-2001

Dr. Sharon Weber trained at Memorial Sloan-Kettering Cancer Center, with dual fellowships in surgical oncology and hepatobiliary. She specializes in benign and malignant disorders of the liver, pancreas and bile duct, in addition to gastric cancer, melanoma and sarcoma.

Clinical Specialties

Dr. Weber is actively involved in minimally invasive approaches to cancer treatment, including both laparoscopic pancreas and liver surgery. She has been invited as a speaker/moderator at many national meetings, including the American College of Surgeons, the American Hepatopancreaticobiliary Association, Society of Surgical Oncology, and Society of University Surgeons.

Dr. Weber provides a wide range of services including Bile Duct Resection, Caudate Resection, Cryoablation, Cyst Fenestration (Unroof Liver Cyst), Cytoreductive Surgery with HIPEC, Frey Procedure, Gastrectomy - Partial or Total, Hemihepatectomy (Hepatectomy), Laparoscopic Liver Resection, Laparoscopic Pancreatectomy, Liver Resection, Liver Tumor Ablations, Melanoma Completion Lymph Node Dissection (Axillary and Groin), Melanoma Sentinel Lymph Node Biopsy, Melanoma Wide Local Excision and Skin Closure, Obstructed Pancreatic Duct Drainage (Peustow Procedure), Pancreatic Head Resection, Pancreaticoduodenectomy, Pancreatic Pseudocysts Drainage, Pancreatic Resections, (show all).

Research Interests

Dr. Weber conducts translational research at the UW Carbone Cancer Center evaluating novel tumor selective agents which may be promising for imaging and/or treating tumors. She also conducts clinical research evaluating prognosticators of outcome in patients with liver, bile duct, and liver tumors.

Active Clinical Trials
  • A Phase II Study of Preoperative Gemcitabine and Erlotinib Plus Pancreatectomy and Postoperative Gemcitabine and Erlotinib for Patients With Operable Pancreatic Adenocarcinoma
    Principal Investigator(s): Sharon M Weber, MD, FACS
    Status: Active, not recruiting
    [ClinicalTrials.gov: NCT00733746]
    More Information

Recent Publications
  • 30-day Readmission After Pancreatic Resection: A Systematic Review of the Literature and Meta-analysis.
    Fisher AV, Fernandes-Taylor S, Campbell-Flohr SA, Clarkson SJ, Winslow ER, Abbott DE, Weber SM
    Ann. Surg. 2017 Aug; 266(2):242-250.
    [PubMed ID: 28323675]
    More Information
  • Blood Transfusion and Survival for Resected Adrenocortical Carcinoma: A Study from the United States Adrenocortical Carcinoma Group.
    Poorman CE, Postlewait LM, Ethun CG, Tran TB, Prescott JD, Pawlik TM, Wang TS, Glenn J, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Staley CA, Poultsides GA, Maithel SK
    Am Surg 2017 Jul 01; 83(7):761-768.
    [PubMed ID: 28738949]
    More Information
  • Pathologic and Prognostic Implications of Incidental versus Nonincidental Gallbladder Cancer: A 10-Institution Study from the United States Extrahepatic Biliary Malignancy Consortium.
    Ethun CG, Le N, Lopez-Aguiar AG, Pawlik TM, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Krasnick BA, Weber SM, Salem A, Martin RCG, Scoggins CR, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Russell MC, Maithel SK
    Am Surg 2017 Jul 01; 83(7):679-686.
    [PubMed ID: 28738935]
    More Information
  • Time to Initiation of Adjuvant Chemotherapy in Pancreas Cancer: A Multi-Institutional Experience.
    Xia BT, Ahmad SA, Al Humaidi AH, Hanseman DJ, Ethun CG, Maithel SK, Kooby DA, Salem A, Cho CS, Weber SM, Stocker SJ, Talamonti MS, Bentrem DJ, Abbott DE
    Ann. Surg. Oncol. 2017 Sep; 24(9):2770-2776.
    [PubMed ID: 28600732]
    More Information
  • Impact of lymph node ratio in selecting patients with resected gastric cancer for adjuvant therapy.
    Kim Y, Squires MH, Poultsides GA, Fields RC, Weber SM, Votanopoulos KI, Kooby DA, Worhunsky DJ, Jin LX, Hawkins WG, Acher AW, Cho CS, Saunders N, Levine EA, Schmidt CR, Maithel SK, Pawlik TM
    Surgery 2017 Aug; 162(2):285-294.
    [PubMed ID: 28578142]
    More Information

webmaster@surgery.wisc.edu Copyright © 2017 The Board of Regents of the University of Wisconsin System